These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29973475)

  • 1. Effect of dosing frequency of teriparatide (PTH 1-34) on bone formation in rats: comparison of bone metabolism marker levels.
    Watanabe A; Tsurui K; Yoneyama S; Iwata H; Anzai T; Jerome C; Nakae D
    J Toxicol Sci; 2018; 43(7):435-442. PubMed ID: 29973475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of changes in bone turnover markers during once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis.
    Sugimoto T; Nakamura T; Nakamura Y; Isogai Y; Shiraki M
    Osteoporos Int; 2014 Mar; 25(3):1173-80. PubMed ID: 24108429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women.
    Shiraki M; Sugimoto T; Nakamura T
    Osteoporos Int; 2013 Jan; 24(1):219-26. PubMed ID: 23093347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship of pharmacokinetics, changes of bone turnover markers and BMD/fractures efficacy during treatment with anabolic agents;Teriparatide daily and once weekly subcutaneous injections.].
    Miyauchi A
    Clin Calcium; 2016; 26(11):1583-1595. PubMed ID: 27777391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of parathyroid hormone (teriparatide) on bone quality in osteoporosis].
    Saito M; Marumo K
    Clin Calcium; 2012 Mar; 22(3):343-55. PubMed ID: 22370301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence in the treatment of osteoporosis using weekly teriparatide injections].
    Nakamura Y
    Clin Calcium; 2012 Mar; 22(3):407-13. PubMed ID: 22370308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring bone turnover markers during treatment with the anabolic agent teriparatide; in particular, treatment using daily and weekly subucutaneous injections].
    Miyauchi A
    Clin Calcium; 2012 Mar; 22(3):387-98. PubMed ID: 22370306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice-weekly teriparatide improves lumbar spine BMD independent of pre-treatment BMD and bone turnover marker levels.
    Takada J; Yoshimura T; Uzawa T
    J Bone Miner Metab; 2021 May; 39(3):484-493. PubMed ID: 33389132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute development of cortical porosity and endosteal naïve bone formation from the daily but not weekly short-term administration of PTH in rabbit.
    Yamane H; Takakura A; Shimadzu Y; Kodama T; Lee JW; Isogai Y; Ishizuya T; Takao-Kawabata R; Iimura T
    PLoS One; 2017; 12(4):e0175329. PubMed ID: 28394900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY.
    Gopalaswamy V; Dhibar DP; Gupta V; Arya AK; Khandelwal N; Bhansali A; Garg SK; Agarwal N; Rao SD; Bhadada SK
    Endocr Pract; 2017 Jun; 23(6):657-661. PubMed ID: 28225309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and robust response of biochemical markers of bone formation to teriparatide therapy.
    Glover SJ; Eastell R; McCloskey EV; Rogers A; Garnero P; Lowery J; Belleli R; Wright TM; John MR
    Bone; 2009 Dec; 45(6):1053-8. PubMed ID: 19679211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cortical porosity is associated with daily, not weekly, administration of equivalent doses of teriparatide.
    Zebaze R; Takao-Kawabata R; Peng Y; Zadeh AG; Hirano K; Yamane H; Takakura A; Isogai Y; Ishizuya T; Seeman E
    Bone; 2017 Jun; 99():80-84. PubMed ID: 28323145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
    Niimi R; Kono T; Nishihara A; Hasegawa M; Matsumine A; Kono T; Sudo A
    Osteoporos Int; 2016 May; 27(5):1869-74. PubMed ID: 26759334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men.
    Finkelstein JS; Leder BZ; Burnett SM; Wyland JJ; Lee H; de la Paz AV; Gibson K; Neer RM
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2882-7. PubMed ID: 16684825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB
    J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic agents for disorders of bone and calcium metabolism: Weekly subcutaneous injection of teriparatide.].
    Ishizuya T
    Clin Calcium; 2011 Jan; 21(1):17-24. PubMed ID: 21187590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in Hypoparathyroidism.
    Gafni RI; Guthrie LC; Kelly MH; Brillante BA; Christie CM; Reynolds JC; Yovetich NA; James R; Collins MT
    J Bone Miner Res; 2015 Nov; 30(11):2112-8. PubMed ID: 25990370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anabolic action of PTH under the loading/unloading condition].
    Sakai A
    Clin Calcium; 2012 Mar; 22(3):365-71. PubMed ID: 22370303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.